17 Results for "

Ndrg1

" in MedChemExpress (MCE) Product Catalog:
Products (17)

17 Results for "Ndrg1" in MCE Product Catalog:

5
5 Cited Publications
Cat. No.: HY-125878
CAS No.: 2381320-35-8
Purity:  99.89%
Synonyms: SGK3-PROTAC1
Target:  

PROTACs SGK

Research Areas:  

Cancer

PROTAC SGK3 degrader-1 (SGK3-PROTAC1), a chemical probe, is a von Hippel-Lindau ligand-based SKG3 PROTAC composed of a PEG3-C4-OBn (HY-130620) alkyl linker, an SGK3 degrader (red structure), and a VHL ligand (HY-150803, blue structure). PROTAC SGK3 degrader-1 (0.3 μM) induced 50% endogenous SGK3 degradation within 2 hours, and 80% SGK3 degradation was observed at 8 hours, accompanied by loss of phosphorylation of NDRG1 (SGK3 substrate) [1].
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-145752
CAS No.: 2365478-58-4
Purity:  98.18%
Target:  

PROTACs SGK PI3K

Research Areas:  

Cancer

HaloPROTAC-E is a SGK3/VPS34 HaloPROTAC degrader that degrades Halo-tagged SGK3 and VPS34, with a DC50 of 3-10 nM in HEK293 cells. HaloPROTAC-E induces ubiquitination and proteasomal degradation of target proteins. HaloPROTAC-E blocks downstream phosphorylation of SGK3 substrate NDRG1. HaloPROTAC-E is applicable for cancer research [1].
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-145723
CAS No.: 2070931-57-4
Purity:  97.04%
Target:  

FLT3 FGFR

Research Areas:  

Inflammation/Immunology Cancer

MAX-40279 is a dual and orally active inhibitor of FLT3 kinase and FGFR kinase. MAX-40279 is also effective against the FLT3 mutants such as FLT3 D835Y, suggesting that it can overcome resistance to Quizartinib (HY-13001) and Sorafenib (HY-10201). MAX-40279 inhibits NDRG1 phosphorylation at Ser330 and suppresses endothelial-to-mesenchymal transition (EndMT). MAX-40279 can be used for the research of acute myelogenous leukemia (AML) [1] .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-145723C
CAS No.: 2388506-44-1
Purity:  99.26%
Target:  

FLT3 FGFR

Research Areas:  

Inflammation/Immunology Cancer

MAX-40279 hemiadipate is a dual and orally active inhibitor of FLT3 kinase and FGFR kinase. MAX-40279 hemiadipate is also effective against the FLT3 mutants such as FLT3 D835Y, suggesting that it can overcome resistance to Quizartinib (HY-13001) and Sorafenib (HY-10201). MAX-40279 hemiadipate inhibits NDRG1 phosphorylation at Ser330 and suppresses endothelial-to-mesenchymal transition (EndMT). MAX-40279 hemiadipate can be used for the research of acute myelogenous leukemia (AML) [1] .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-145723B
CAS No.: 2388506-43-0
Purity:  99.56%
Target:  

FLT3 FGFR

Research Areas:  

Inflammation/Immunology Cancer

MAX-40279 hemifumarate is a dual and orally active inhibitor of FLT3 kinase and FGFR kinase. MAX-40279 hemifumarate is also effective against the FLT3 mutants such as FLT3 D835Y, suggesting that it can overcome resistance to Quizartinib (HY-13001) and Sorafenib (HY-10201). MAX-40279 hemifumarate inhibits NDRG1 phosphorylation at Ser330 and suppresses endothelial-to-mesenchymal transition (EndMT). MAX-40279 hemifumarate can be used for the research of acute myelogenous leukemia (AML) [1] .
loading...
    loading...
Cat. No.: HY-RS17382
Research Areas:  

Others

Ndrg1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ndrg1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS09114
Research Areas:  

Others

NDRG1 Human Pre-designed siRNA Set A contains three designed siRNAs for NDRG1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-15193B
CAS No.: 1184940-46-2
Purity:  99.95%
Target:  

SGK Drug Isomer

Research Areas:  

Cardiovascular Disease Cancer

EMD638683 (S-Form) (Compound 1a), the S-enantiomer of EMD638683 (HY-15193), is a SGK1 inhibitor with an IC50 value > 300 nM. EMD638683 is an orally active SGK1 inhibitor with an IC50 of 3 μM. EMD638683 exhibits strong inhibition against SGK1, moderate inhibition against SGK2 and SGK3, and shows excellent selectivity for other AGC kinase family members. EMD638683 has antihypertensive activity by inhibiting SGK1, and independently of the blood pressure-lowering effect, it effectively prevents heart inflammation and fibrosis caused by hypertension by inhibiting the cardiac NLRP3 inflammation body/ IL-1β axis. EMD638683 promotes apoptosis of colon cancer cells and sensitizes radiotherapy. EMD638683 (S-Form) can be used in research related to hypertension, hypertensive heart damage, and colon cancer [1] .
loading...
    loading...
Cat. No.: HY-RS23837
Research Areas:  

Others

Ndrg1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Ndrg1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-176823
CAS No.: 2381196-78-5
Target:  

PROTACs SGK

Research Areas:  

Cancer

PROTAC SGK3 degrader-2 is the cis epimer of PROTAC SGK3 degrader-1 (SGK3-PROTAC1) (HY-125878). PROTAC SGK3 degrader-2 exhibits inhibitory activity against SGK3, SGK1 and S6K1, with IC50 values of 0.6 μM, 1.4 μM and 1.7 μM, respectively, but fails to degrade SGK3. PROTAC SGK3 degrader-2 can serve as a control compound to investigate the specific effects of SGK3 degradation mediated by SGK3-PROTAC1 [1].
loading...
    loading...
Cat. No.: HY-145723A
CAS No.: 2388506-51-0
Target:  

FLT3 FGFR

Research Areas:  

Inflammation/Immunology Cancer

MAX-40279 hydrochloride is a dual and orally active inhibitor of FLT3 kinase and FGFR kinase. MAX-40279 hydrochloride is also effective against the FLT3 mutants such as FLT3 D835Y, suggesting that it can overcome resistance to Quizartinib (HY-13001) and Sorafenib (HY-10201). MAX-40279 hydrochloride inhibits NDRG1 phosphorylation at Ser330 and suppresses endothelial-to-mesenchymal transition (EndMT). MAX-40279 hydrochloride can be used for the research of acute myelogenous leukemia (AML) [1] .
loading...
    loading...
Cat. No.: HY-P82873
Synonyms: Protein Ndrg1; Differentiation-related gene 1 protein; DRG-1; RTP; Rit42; Ndrg1; CAP43; DRG1; RTP; targ1; TDD5; tdds

Host:  

Rabbit

Application:  

WB, IHC-F, IHC-P, ICC/IF, IP

Reactivity:  

Human, Mouse

loading...
    loading...
Cat. No.: HY-P82873A
Synonyms: Protein Ndrg1; Differentiation-related gene 1 protein; DRG-1; RTP; Rit42; Ndrg1; CAP43; DRG1; RTP; targ1; TDD5; tdds

Host:  

Rabbit

Application:  

WB, IHC-F, IHC-P, ICC/IF, IP

Reactivity:  

Human, Mouse

loading...
    loading...
Cat. No.: HY-P70886
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Ndrg1; Protein Ndrg1; Prev. CAP43; Protein Regulated By Oxygen-1; DRG1; PROXY1; RTP; CMT4D; TDD5; HMSNL; NDR1; RIT42; Reducing Agents And Tunicamycin-Responsive Protein; TARG1; N-Myc Downstream-Regulated Gene 1 Protein; Rit42; Nickel-Specific Induction Pr
Species:  
Human
Source:  
E. coli
loading...
    loading...
Cat. No.: HY-P86171

Host:  

Rabbit

Application:  

WB, IHC-P, ICC/IF, IP, ELISA

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-P80239
Synonyms: CAP43, DRG1, RTP, Ndrg1, Protein Ndrg1, Differentiation-related gene 1 protein, N-myc downstream-regulated gene 1 protein, Nickel-specific induction protein Cap43, Reducing agents and tunicamycin-responsive protein, Rit42, DRG-1

Host:  

Rabbit

Application:  

WB, ICC/IF, IHC-P, IP

Reactivity:  

Human, Mouse

loading...
    loading...
Cat. No.: HY-151009
CAS No.: 2376724-98-8
308-R is a SGK3/SGK1/S6K1 inhibitor. 308-R exhibits an IC50 of 5 nM against human SGK3, an IC50 of 10 nM against human SGK1, and an IC50 of 1 nM against human S6K1. 308-R can be used in breast cancer research. It is also applicable to studies related to PROTAC synthesis, such as serving as the target protein ligand for PROTAC SGK3 degrader-2 (HY-176823) [1].
loading...
    loading...
  • 1